Tumor promotion in liver of mice with a conditional Cx26 knockout

Toxicological Sciences

Volumn 103, Issue 2, 2008, Pages 260-267

  Marx Stoelting, Philip ^a   Mahr, Johanna ^a   Knorpp, Thomas ^b   Schreiber, Sandra ^a   Templin, Markus F ^b   Ott, Thomas ^c   Buchmann, Albrecht ^a   Schwarz, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

catenin; Connexin; Liver; Phenobarbital; Tumor promotion

Indexed keywords

CONNEXIN 26; DIETHYLNITROSAMINE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SIZE; CONTROLLED STUDY; KNOCKOUT MOUSE; LIVER CARCINOGENESIS; LIVER WEIGHT; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; WILD TYPE;

ANIMALS; APOPTOSIS; CARCINOGENS; COCARCINOGENESIS; CONNEXINS; DIETHYLNITROSAMINE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; ORGAN SIZE; PROTEIN ARRAY ANALYSIS; RNA, NEOPLASM;

MUS;

EID: 43349094447     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn043     Document Type: Article

References (32)

1. Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A., and Schwarz, M. (2001). Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene 20, 7812-7816.
2. Campbell, H. A., Pitot, H. C., Potter, V. R., and Laishes, B. A. (1982). Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver. Cancer Res. 42, 465-472.
3. Chen, Y., Huhn, D., Knosel, T., Pacyna-Gengelbash, M., Deutschmann, N., and Petersen, I. (2005). Downregulation of connexin 26 in human lung cancer is related to promoter methylation. Int. J. Cancer 113 14-21.
4. Chipman, J. K., Mally, A., and Edwards, G. O. (2003). Disruption of gap junctions in toxicity and carcinogenicity. Toxicol. Sci. 71, 146-153.
5. Cohen-Salmon, M., Ott, T., Michel, Y., Hardelin, J. P., Perfettini, I., Eybalin, M., Wu, T., Marcus, D. C., Wangemann, P., Willecke, K., et al. (2002). Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr. Biol. 12, 1106-1111.
6. Evert, M., Ott, T., Temme, A., Willecke, K., and Dombrowski, F. (2002). Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice. Carcinogenesis 23, 697-703.
7. Goldberg, G. S., Lampe, P. D., and Nicholson, B. J. (1999). Selective transfer of endogenous metabolites through gap junctions composed of different connexins. Nat. Cell Biol. 1, 457-459.
8. Goldberg, G. S., Valiunas, V., and Brink, P. R. (2004). Selective permeability of gap junction channels. Biochim. Biophys. Acta 1662, 96-101.
9. Kumar, N. M., and Gilula, N. B. (1996). The gap junction communication channel. Cell 84, 381-388.
10. Land, D. W. (2006). Life cycle of connexins in health and disease. Biochem. J. 394, 527-543.
11. Lampe, P. D., and Lau, A. F. (2000). Regulation of gap junctions by phosphorylation of connexins. Arch. Biochem. Biophys. 384, 205-215.
12. Lee, S. W., Tomasetto, C., and Sager, R. (1991). Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc. Natl. Acad. Sci. U.S.A. 88, 2825-2829.
13. Locke, D., Koreen, I. V., and Harris, A. L. (2006). Isoelectric points and post-translational modifications of connexin26 and connexin32. FASEB J. 20, 1221-1223.
14. Loeppen, S., Koehle, C., Buchmann, A., and Schwarz, M. (2005). A betacatenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis 26, 239-248.
15. Loeppen, S., Schneider, D., Gaunitz, F., Gebhardt, R., Kurek, R., Buchmann, A., and Schwarz, M. (2002). Overexpression of glutamine synthetase is associated with beta-tatenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res. 62, 5685-5688.
16. Mesnil, M. (2002). Connexins and cancer. Biol. Cell 94, 493-500.
17. Mesnil, M., Crespin, S., Avanzo, J. L., and Zaidan-Dagli, M. L. (2005). Defective gap junctional intercellular communication in the carcinogenic process. Biochim. Biophys. Acta 1719, 125-145.
18. Moennikes, O., Buchmann, A., Ott, T., Willecke, K., and Schwarz, M. (1999). The effect of connexin32 null mutation oni hepatocarcinogenesis in different mouse strains. Carcinogenesis 20, 1379-1382.
19. Moennikes, O., Buchmann, A., Romualdi, A., Ott, T., Werringloer, J., Willecke, K., and Schwarz, M. (2000). Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Cancer Res. 60, 5087-5091.
20. Moreno, A. P., and Lau, A. F. (2007). Gap junction channel gating modulated through protein phosphorylation. Prog. Biophys. Mol. Biol. 94, 107-119.
21. Ott, T., Jokwitz, M., Lenhard, D., Romualdi, A., Dombrowski, F., Ittrich, C., Schwarz, M., and Willecke, K. (2006). Ablation of gap junctional communication in hepatocytes of transgenic mice does not lead to disrupted cellular homeostasis or increased spontaneous tumourigenesis. Eur. J. Cell. Biol. 85, 717-728.
22. Pawlak, M., Schick, E., Bopp, M. A., Schneider, M. J., Oroszlan, P., and Ehrat, M. (2002). Zeptosens' protein microarrays: A novel high performance microarray platform for low abundance protein analysis. Proteomics 2, 383-393.
23. R-Development-Core-Team. (2004). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, ISBN 3-9000051-00-3. Available at: http://www.R-project.org.
24. Saez, J. C., Nairn, A. C., Czernik, A. J., Spray, D. C., Hertzberg, E. L., Greengard, P., and Bennett, M. V. (1990). Phosphorylation of connexin 32, a hepatocyte gap-junction protein, by cAMP-depeudent protein kinase, protein kinase C. and Ca2+/calmodulin-dependent pretein kinase II. Eur. J. Bioehem. 192, 263-273.
25. Temme, A., Buchmann, A., Gabriel, H. D., Nelles, E., Schwarz, M., and Willecke, K. (1997). High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr. Biol. 7, 713-716.
26. Traub, O., Look, J., Dermietzel, R., Brummer, F., Hulser, D., and Willecke, K. (1989). Comparative characterization of the 21-kD and 26-kD gap junction proteins in murine liver and cultured hepatocytes. J. Cell Biol. 108, 1039-1051.
27. Trosko, J. E., and Ruch, R. J. (1998). Cell-cell communication in carcinogenesis. Front. Biosci. 3, d208-d236.
28. Trosko, J. E., and Ruch, R. J. (2002). Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr. Drug Targets 3 465-482.
29. Vinken, M., Vanhaecke, T., Papeleu, P., Snykers, S., Henkens, T., and Rogiers, V. (2006). Connexins and their channels in cell growth and cell death. Cell Signal. 18, 592-600.
30. Wachstein, M., and Meisel, E. (1957). Histochemistry of hepatic phosphatases of a physiologic pH; with special reference to the demonstration of bile canaliculi. Am. J. Clin. Pathol. 27, 13-23.
31. Willecke, K., Eiberger, J., Degen, J., Eckardt, D., Romualdi, A., Guldenagel, M., Deutsch, U., and Sohl, G. (2002). Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem. 383, 725-737.
32. Yamasaki, H., Mesnil, M., Omori, Y.; Mironov, N., and Krutovskikh, V. (1995). Intercellular communication and carcinogenesis. Mutat. Res. 333, 181-188.